AXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement

• Post author:GHIAA Admin
• Post published:September 13, 2022
• Post category:

Continue ReadingAXA Prime Impact Master Fund – Revelation Biosciences, Diagnostics & Therapeutics for Viral Infections, Global Health Agreement

Alnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement

• Post author:GHIAA Admin
• Post published:September 6, 2022
• Post category:

Continue ReadingAlnylam Pharmaceuticals – University of British Columbia- AlCana Technology, Sponsored Research Agreement

Gates Foundation – Icosavax, COVID-19 Vaccine Global Access and Price Commitments Agreement

• Post author:GHIAA Admin
• Post published:August 11, 2022
• Post category:

Continue ReadingGates Foundation – Icosavax, COVID-19 Vaccine Global Access and Price Commitments Agreement

Shionogi – GARDP, Cefiderocol License Agreement

• Post author:GHIAA Admin
• Post published:July 7, 2022
• Post category:

Continue ReadingShionogi – GARDP, Cefiderocol License Agreement

NIH – MPP, COVID-19 Patent and Biological Material License Agreement

• Post author:GHIAA Admin
• Post published:June 29, 2022
• Post category:

Continue ReadingNIH – MPP, COVID-19 Patent and Biological Material License Agreement

Entasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement

• Post author:GHIAA Admin
• Post published:June 7, 2022
• Post category:

Continue ReadingEntasis – DNDi/GARDP, Gonorrhoea Medication, Collaboration Agreement

Elkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement

• Post author:GHIAA Admin
• Post published:May 27, 2022
• Post category:

Continue ReadingElkurt – Ocean Biomedical, Malaria Vaccine, Exclusive License Agreement

CSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

• Post author:GHIAA Admin
• Post published:May 23, 2022
• Post category:

Continue ReadingCSIC-MPP, COVID-19 Antibody Diagnostic, Patent & Material License Agreement

Gates Foundation – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement

• Post author:GHIAA Admin
• Post published:April 25, 2022
• Post category:

Continue ReadingGates Foundation – Arsanis, S. Aureus Antibody Strategic Relationship Letter Agreement